Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum.

Bosch I, de Puig H, Hiley M, Carré-Camps M, Perdomo-Celis F, Narváez CF, Salgado DM, Senthoor D, O'Grady M, Phillips E, Durbin A, Fandos D, Miyazaki H, Yen CW, Gélvez-Ramírez M, Warke RV, Ribeiro LS, Teixeira MM, Almeida RP, Muñóz-Medina JE, Ludert JE, Nogueira ML, Colombo TE, Terzian ACB, Bozza PT, Calheiros AS, Vieira YR, Barbosa-Lima G, Vizzoni A, Cerbino-Neto J, Bozza FA, Souza TML, Trugilho MRO, de Filippis AMB, de Sequeira PC, Marques ETA, Magalhaes T, Díaz FJ, Restrepo BN, Marín K, Mattar S, Olson D, Asturias EJ, Lucera M, Singla M, Medigeshi GR, de Bosch N, Tam J, Gómez-Márquez J, Clavet C, Villar L, Hamad-Schifferli K, Gehrke L.

Sci Transl Med. 2017 Sep 27;9(409). pii: eaan1589. doi: 10.1126/scitranslmed.aan1589.

2.

Drug susceptibility of influenza A/H3N2 strains co-circulating during 2009 influenza pandemic: first report from Mumbai.

Gohil DJ, Kothari ST, Shinde PS, Chintakrindi AS, Meharunkar R, Warke RV, Kanyalkar MA, Chowdhary AS, Deshmukh RA.

Infect Genet Evol. 2015 Jan;29:75-81. doi: 10.1016/j.meegid.2014.11.005. Epub 2014 Nov 11.

PMID:
25461259
3.

Gene expression profiling of dengue infected human primary cells identifies secreted mediators in vivo.

Becerra A, Warke RV, Martin K, Xhaja K, de Bosch N, Rothman AL, Bosch I.

J Med Virol. 2009 Aug;81(8):1403-11. doi: 10.1002/jmv.21538.

4.

Increased activity of indoleamine 2,3-dioxygenase in serum from acutely infected dengue patients linked to gamma interferon antiviral function.

Becerra A, Warke RV, Xhaja K, Evans B, Evans J, Martin K, de Bosch N, Rothman AL, Bosch I.

J Gen Virol. 2009 Apr;90(Pt 4):810-7. doi: 10.1099/vir.0.004416-0. Epub 2009 Mar 4.

5.

Efficient dengue virus (DENV) infection of human muscle satellite cells upregulates type I interferon response genes and differentially modulates MHC I expression on bystander and DENV-infected cells.

Warke RV, Becerra A, Zawadzka A, Schmidt DJ, Martin KJ, Giaya K, Dinsmore JH, Woda M, Hendricks G, Levine T, Rothman AL, Bosch I.

J Gen Virol. 2008 Jul;89(Pt 7):1605-15. doi: 10.1099/vir.0.2008/000968-0.

PMID:
18559930
6.

Elevated levels of soluble ST2 protein in dengue virus infected patients.

Becerra A, Warke RV, de Bosch N, Rothman AL, Bosch I.

Cytokine. 2008 Feb;41(2):114-20. doi: 10.1016/j.cyto.2007.11.001. Epub 2008 Jan 28.

7.

TRAIL is a novel antiviral protein against dengue virus.

Warke RV, Martin KJ, Giaya K, Shaw SK, Rothman AL, Bosch I.

J Virol. 2008 Jan;82(1):555-64. Epub 2007 Oct 3.

8.

Discovering innate immunity genes using differential display: a story of RNA helicases.

Ramirez-Ortiz ZG, Warke RV, Pacheco L, Xhaja K, Sarkar D, Fisher PB, Shaw SK, Martin KJ, Bosch I.

J Cell Physiol. 2006 Dec;209(3):636-44.

PMID:
17001675
9.

Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells.

Warke RV, Xhaja K, Martin KJ, Fournier MF, Shaw SK, Brizuela N, de Bosch N, Lapointe D, Ennis FA, Rothman AL, Bosch I.

J Virol. 2003 Nov;77(21):11822-32. Erratum in: J Virol. 2004 May;78(9):4947-8.

10.

Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge.

Bosch I, Xhaja K, Estevez L, Raines G, Melichar H, Warke RV, Fournier MV, Ennis FA, Rothman AL.

J Virol. 2002 Jun;76(11):5588-97.

Supplemental Content

Loading ...
Support Center